FutraMed Inc. was founded in the State of Utah in 2011 for the purpose of engaging in the creation and application of technology to provide solutions for individuals with substance abuse and other physical and behavioral limitations. With the consumption of painkillers soaring throughout the world, FutraMed has developed a patented medical device that is a hand-held, portable, battery-powered, cranial stimulator called the Limoge TCES. It is used to stabilize, reduce or replace dosages of opioids prescribed in the treatment of pain conditions, both acute and chronic. A fully functional, IEC compliant, manufacturer-ready device has been created and we are now working with regulatoy agencies to allow the device to be available for the public. The technology for the device, a transcutaneous electrical cranial stimulator, is based on the work of Dr. Aimé Limoge of Paris France and the Limoge Current which he developed. Numerous studies have been performed using the Limoge Current showing that it enhances the treatment for pain and reduces the need for opioids. In collaboration with Dr. Limoge and his associates, our team was able to effectively replicate the Limoge Current and create a device that is simple to use, low cost, battery powered, meets regulatory requirements, and is easy to manufacture.